BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35106500)

  • 1. Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline.
    Sienkiewicz K; Ratan A
    STAR Protoc; 2022 Mar; 3(1):101110. PubMed ID: 35106500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders.
    Gu T; Zhao X
    Sci Rep; 2019 Nov; 9(1):16668. PubMed ID: 31723226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting molecular subtypes from multi-omics datasets using SUMO.
    Sienkiewicz K; Chen J; Chatrath A; Lawson JT; Sheffield NC; Zhang L; Ratan A
    Cell Rep Methods; 2022 Jan; 2(1):. PubMed ID: 35211690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.
    Robertson AG; Yau C; Carrot-Zhang J; Damrauer JS; Knijnenburg TA; Chambwe N; Hoadley KA; Kemal A; Zenklusen JC; Cherniack AD; Beroukhim R; Zhou W
    STAR Protoc; 2021 Jun; 2(2):100483. PubMed ID: 33982016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
    Salazar DA; Pržulj N; Valencia CF
    Bioinformatics; 2021 Dec; 37(24):4801-4809. PubMed ID: 34375392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational pipeline to visualize DNA-protein binding states using dSMF data.
    Rao S; Ramachandran S
    STAR Protoc; 2022 Jun; 3(2):101299. PubMed ID: 35463472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatic pipeline using whole-exome and RNAseq data to identify germline variants correlated with cancer.
    Sahu D; Chatrath A; Ratan A; Dutta A
    STAR Protoc; 2022 Jun; 3(2):101273. PubMed ID: 35403010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICRORNA-AUGMENTED PATHWAYS (mirAP) AND THEIR APPLICATIONS TO PATHWAY ANALYSIS AND DISEASE SUBTYPING.
    Diaz D; Donato M; Nguyen T; Draghici S
    Pac Symp Biocomput; 2017; 22():390-401. PubMed ID: 27896992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical Methods for Integrative Clustering of Multi-omics Data.
    Chalise P; Kwon D; Fridley BL; Mo Q
    Methods Mol Biol; 2023; 2629():73-93. PubMed ID: 36929074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG).
    Liu H; Wang J; Luo T; Zhen Z; Liu L; Zheng Y; Zhang C; Hu X
    Front Endocrinol (Lausanne); 2022; 13():1106120. PubMed ID: 36714574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
    Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
    Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for dissecting cascade computational components in neural networks of a visual system.
    Jia S; Liu JK; Yu Z
    STAR Protoc; 2023 Dec; 4(4):102722. PubMed ID: 37976152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping.
    Munquad S; Das AB
    BioData Min; 2023 Nov; 16(1):32. PubMed ID: 37968655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
    Yang Y; Sui Y; Xie B; Qu H; Fang X
    Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):465-471. PubMed ID: 31811943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification.
    Duan X; Ding X; Zhao Z
    J Transl Med; 2024 Jan; 22(1):79. PubMed ID: 38243340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.